Carsten Skarke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carsten Skarke has a total of 383 co-authors. Here are the top co-authors by number of shared publications:
- Jörn Lötsch
Goethe University, Institute of Clinical Pharmacology, Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
27 shared publications Gerd Geisslinger
20 shared publications- Garret A. FitzGerald
Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
15 shared publications Garret A. FitzGerald
University of Pennsylvania
10 shared publicationsNicholas F. Lahens
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
10 shared publicationsHelmut Schmidt
Pharmacist
9 shared publications
Latest Publications
- 23 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (43) , eaeg5357
Furan fatty acids reprogram hepatic lipid metabolism via acyl-CoA conjugates in obesity
Dietary fish oil (FO) and omega-3 fatty acids are associated with cardiometabolic benefits, yet their molecular mediators remain incompletely defined. Furan fatty acids (FuFAs), a distinct lipid class enriched in FO, have emerged as potential regulators of metabolic health. Here, we identify and quantify FuFA species in prescription omega-3 formulations and natural fish oils, and synthesize structurally engineered analogs designed to isolate antioxidant activity and β-oxidation susceptibility from FuFA bioactivity. In a diet-induced obesity mouse model, both natural and synthetic FuFAs reduced fat accumulation and inflammatory markers, while 11U3-2M additionally produced significant improvement in glucose tolerance, dyslipidemia, and hepatic steatosis. The superior activity of 11U3-2M reflects the stable accumulation of its acyl-CoA conjugate that activates peroxisome proliferator-activated receptor alpha (PPARα) signaling and allosterically inhibits acetyl-CoA carboxylases (ACCs) to reprogram hepatic lipid metabolism. These findings position FuFAs as functional dietary lipids contributing to fish oil’s metabolic effects and define fatty acid structural determinants that govern hepatic metabolic activity.
- 23 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (43) , eaeg5357
Furan fatty acids reprogram hepatic lipid metabolism via acyl-CoA conjugates in obesity
Dietary fish oil (FO) and omega-3 fatty acids are associated with cardiometabolic benefits, yet their molecular mediators remain incompletely defined. Furan fatty acids (FuFAs), a distinct lipid class enriched in FO, have emerged as potential regulators of metabolic health. Here, we identify and quantify FuFA species in prescription omega-3 formulations and natural fish oils, and synthesize structurally engineered analogs designed to isolate antioxidant activity and β-oxidation susceptibility from FuFA bioactivity. In a diet-induced obesity mouse model, both natural and synthetic FuFAs reduced fat accumulation and inflammatory markers, while 11U3-2M additionally produced significant improvement in glucose tolerance, dyslipidemia, and hepatic steatosis. The superior activity of 11U3-2M reflects the stable accumulation of its acyl-CoA conjugate that activates peroxisome proliferator-activated receptor alpha (PPARα) signaling and allosterically inhibits acetyl-CoA carboxylases (ACCs) to reprogram hepatic lipid metabolism. These findings position FuFAs as functional dietary lipids contributing to fish oil’s metabolic effects and define fatty acid structural determinants that govern hepatic metabolic activity.
- 17 September 2026
- Published by Elsevier in Cell Chemical Biology
- Vol. 33 (9) , 1252-1269.e5
Nitrated fatty acids form membrane biochemical capacitors that restrain inflammation
- 17 September 2026
- Published by Elsevier in Cell Chemical Biology
- Vol. 33 (9) , 1252-1269.e5
Nitrated fatty acids form membrane biochemical capacitors that restrain inflammation
- Open Access
- 28 August 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (10)
Biosynthesis and analytics of specialized pro-resolving mediators: facts and faults
- 28 August 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (10)
Open AccessBiosynthesis and analytics of specialized pro-resolving mediators: facts and faults
- Open Access
- 21 April 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Quantifying sleep wake rhythms in the hospital environment with digital technologies
Postoperative clinical care is prone to circadian desynchronization that may influence health outcomes. In an exploratory, feasibility-oriented and signal-exploration effort, we collected 1.8 million data points using 11 remote sensors during preoperative, in-hospital and post-discharge settings in 13 elective cardiac surgery patients (5.2% enrolled from 252 screened). We found that room traffic continued during nighttime with ≥1 visit/h. Sound levels exceeded the recommended 45 dBA threshold (51.9 ± 3.3 vs. 48.3 ± 4.2 dBA during nighttime). Brightness dropped at night (89.9 ± 87.7 to 3.7 ± 9.8 lux), but bright light exposures occurred. Ambient room temperature lacked sleep-inducing diurnal variability. Behavioral-physiological rhythms were disrupted and phase-shifted during hospitalization. Time awake during night hours increased from 10.7 ± 7.9% preoperatively to 34.8 ± 29.1% in-hospital. Cognitive function scores decreased (26.8 ± 2.8 points preoperatively to 24.7 ± 3.9 points in-hospital) with 31% of patients developing transient mild impairment. These data will inform the design of a controlled trial seeking to modify circadian/diurnal disruptors to enhance patient outcomes. Clinicaltrials.gov NCT05828680, November 21, 2022.
- 21 April 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessQuantifying sleep wake rhythms in the hospital environment with digital technologies
Postoperative clinical care is prone to circadian desynchronization that may influence health outcomes. In an exploratory, feasibility-oriented and signal-exploration effort, we collected 1.8 million data points using 11 remote sensors during preoperative, in-hospital and post-discharge settings in 13 elective cardiac surgery patients (5.2% enrolled from 252 screened). We found that room traffic continued during nighttime with ≥1 visit/h. Sound levels exceeded the recommended 45 dBA threshold (51.9 ± 3.3 vs. 48.3 ± 4.2 dBA during nighttime). Brightness dropped at night (89.9 ± 87.7 to 3.7 ± 9.8 lux), but bright light exposures occurred. Ambient room temperature lacked sleep-inducing diurnal variability. Behavioral-physiological rhythms were disrupted and phase-shifted during hospitalization. Time awake during night hours increased from 10.7 ± 7.9% preoperatively to 34.8 ± 29.1% in-hospital. Cognitive function scores decreased (26.8 ± 2.8 points preoperatively to 24.7 ± 3.9 points in-hospital) with 31% of patients developing transient mild impairment. These data will inform the design of a controlled trial seeking to modify circadian/diurnal disruptors to enhance patient outcomes. Clinicaltrials.gov NCT05828680, November 21, 2022.
- Open Access
TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes
Accurate quantification of individual exposure to air pollutants remains a major challenge in environmental health, as fixed-site monitoring fails to account for mobility, indoor environments, and physiological variability. We deployed TracMyAir, a smartphone-based digital health platform designed to generate time-resolved, personalized exposure and inhaled dose estimates for PM2.5 and ozone under real-world conditions. In an exploratory study of 18 adults contributing more than 1,500 participant-hours, the platform integrated smartphone geolocation, regulatory (AirNow) and community-based (PurpleAir) air quality data, building infiltration modeling, microenvironment classification, and wearable-derived physical activity metrics to compute eight tiers of hourly exposure estimates, culminating in individualized inhaled dose. Hourly dose estimates derived from smartphone- and smartwatch-based step counts were concordant (Spearman correlation p=0.97-0.98), while heart rate-based estimates yielded greater variability and higher mean values (p=0.82-0.92). Exposure explained 51-73% of variance in inhaled dose of PM2.5 and 68-84% of ozone, suggesting that physiological-based modeling approaches improve hyperlocal estimates of personal pollutant burden. Substantial inter- and intra-individual variability reflect dynamic microenvironmental transitions and activity patterns. Modeled doses based on regulatory and community sensor networks were strongly correlated (R=0.84), with community sensors located closer to participants on average, supporting the feasibility of integrating dense, low-cost monitoring networks. No consistent association was observed between outdoor pollutant levels and neighborhood socioeconomic status in this cohort. These findings demonstrate the feasibility of a scalable, smartphone-centered digital health approach for hyperlocal exposure and inhaled dose modeling. By leveraging ubiquitous consumer devices and existing air quality networks, TracMyAir enables personalized environmental exposure assessment with potential applications in epidemiology, population health, and precision environmental medicine.
Open AccessTracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes
Accurate quantification of individual exposure to air pollutants remains a major challenge in environmental health, as fixed-site monitoring fails to account for mobility, indoor environments, and physiological variability. We deployed TracMyAir, a smartphone-based digital health platform designed to generate time-resolved, personalized exposure and inhaled dose estimates for PM2.5 and ozone under real-world conditions. In an exploratory study of 18 adults contributing more than 1,500 participant-hours, the platform integrated smartphone geolocation, regulatory (AirNow) and community-based (PurpleAir) air quality data, building infiltration modeling, microenvironment classification, and wearable-derived physical activity metrics to compute eight tiers of hourly exposure estimates, culminating in individualized inhaled dose. Hourly dose estimates derived from smartphone- and smartwatch-based step counts were concordant (Spearman correlation p=0.97-0.98), while heart rate-based estimates yielded greater variability and higher mean values (p=0.82-0.92). Exposure explained 51-73% of variance in inhaled dose of PM2.5 and 68-84% of ozone, suggesting that physiological-based modeling approaches improve hyperlocal estimates of personal pollutant burden. Substantial inter- and intra-individual variability reflect dynamic microenvironmental transitions and activity patterns. Modeled doses based on regulatory and community sensor networks were strongly correlated (R=0.84), with community sensors located closer to participants on average, supporting the feasibility of integrating dense, low-cost monitoring networks. No consistent association was observed between outdoor pollutant levels and neighborhood socioeconomic status in this cohort. These findings demonstrate the feasibility of a scalable, smartphone-centered digital health approach for hyperlocal exposure and inhaled dose modeling. By leveraging ubiquitous consumer devices and existing air quality networks, TracMyAir enables personalized environmental exposure assessment with potential applications in epidemiology, population health, and precision environmental medicine.
- Open Access
- 1 February 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (2) , e25516
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response
BACKGROUND: Large clinical trials compared distinct nonsteroidal anti-inflammatory drugs in terms of their risk of adverse cardiovascular events. However, whether pharmacologically equipotent doses were used, that is, whether a similar degree of COX (cyclooxygenase)-2 inhibition was achieved, was not considered. We compared drug target inhibition and blood pressure (BP) response to celecoxib and naproxen. METHODS: Sixteen healthy participants were treated with celecoxib (200 mg/d), naproxen (500 mg/d), or placebo for 7 days in a double-blind, crossover design. The degree of COX inhibition was assessed ex vivo using established whole blood assays and in vivo by quantifying urinary metabolites of thromboxane A 2 (COX-1) and prostacyclin (COX-2). Ambulatory BP was measured throughout the final dosing interval. RESULTS: Both nonsteroidal anti-inflammatory drugs inhibited COX-2 activity relative to placebo, but naproxen inhibited COX-2 activity to a greater degree (62.9±21.7%) than celecoxib (35.7±25.2%; P P P P <0.05). CONCLUSIONS: Future studies should consider pharmacokinetic and pharmacodynamic properties, as well as patient-specific factors that may modulate the cardiovascular risk of nonsteroidal anti-inflammatory drug use. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02502006.
- 1 February 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (2) , e25516
Open AccessDegree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response
BACKGROUND: Large clinical trials compared distinct nonsteroidal anti-inflammatory drugs in terms of their risk of adverse cardiovascular events. However, whether pharmacologically equipotent doses were used, that is, whether a similar degree of COX (cyclooxygenase)-2 inhibition was achieved, was not considered. We compared drug target inhibition and blood pressure (BP) response to celecoxib and naproxen. METHODS: Sixteen healthy participants were treated with celecoxib (200 mg/d), naproxen (500 mg/d), or placebo for 7 days in a double-blind, crossover design. The degree of COX inhibition was assessed ex vivo using established whole blood assays and in vivo by quantifying urinary metabolites of thromboxane A 2 (COX-1) and prostacyclin (COX-2). Ambulatory BP was measured throughout the final dosing interval. RESULTS: Both nonsteroidal anti-inflammatory drugs inhibited COX-2 activity relative to placebo, but naproxen inhibited COX-2 activity to a greater degree (62.9±21.7%) than celecoxib (35.7±25.2%; P P P P <0.05). CONCLUSIONS: Future studies should consider pharmacokinetic and pharmacodynamic properties, as well as patient-specific factors that may modulate the cardiovascular risk of nonsteroidal anti-inflammatory drug use. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02502006.
- Open Access
Age and the Diurnal Oscillatory Features of the Human Chronobiome
The molecular clock regulates diverse aspects of human biology. As people age, diurnal rhythms deteriorate, most evidently in the daytime napping and nighttime waking of older individuals. To understand how temporal deconsolidation of oscillatory networks could contribute to age-related disease expression, we studied the chronobiome at unprecedented depth in young and old apparently healthy individuals. Transomic integration segregated age groups and identified candidate mechanisms by which oscillatory function might contribute to age dependent distinctions. In an orthogonal approach, we validated as true cyclers many proteins identified in the UK Biobank as predictors of health and disease outcomes. Here, age-specific alterations in the cycling proteome across disease phenotypes is consistent with our hypothesis that deconsolidated circadian programs associate with increased susceptibility to age-related disease.
Open AccessAge and the Diurnal Oscillatory Features of the Human Chronobiome
The molecular clock regulates diverse aspects of human biology. As people age, diurnal rhythms deteriorate, most evidently in the daytime napping and nighttime waking of older individuals. To understand how temporal deconsolidation of oscillatory networks could contribute to age-related disease expression, we studied the chronobiome at unprecedented depth in young and old apparently healthy individuals. Transomic integration segregated age groups and identified candidate mechanisms by which oscillatory function might contribute to age dependent distinctions. In an orthogonal approach, we validated as true cyclers many proteins identified in the UK Biobank as predictors of health and disease outcomes. Here, age-specific alterations in the cycling proteome across disease phenotypes is consistent with our hypothesis that deconsolidated circadian programs associate with increased susceptibility to age-related disease.
- Open Access
- 21 January 2026
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 10 (1) , 1-19
Art as a multiplier of science communication
Clinical and translational science faces persistent challenges in public trust, effective communication, and siloed knowledge structures. Addressing these issues requires innovative educational and engagement strategies. We present an artist-in-residency program immersed into an undergraduate pathway program to integrate artwork as a tool to enhance science communication, foster public engagement, and build a resilient translational science workforce. Through structured art-science–community interactions, this initiative demonstrates how artistic practice builds a new collaborative communication framework for linking early-career scientists, clinical translational research faculty, and the broader community. The conceptual novelty of our science-art initiative promises to break communication barriers, increase public trust, and develop new, accessible science narratives.
- 21 January 2026
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 10 (1) , 1-19
Open AccessArt as a multiplier of science communication
Clinical and translational science faces persistent challenges in public trust, effective communication, and siloed knowledge structures. Addressing these issues requires innovative educational and engagement strategies. We present an artist-in-residency program immersed into an undergraduate pathway program to integrate artwork as a tool to enhance science communication, foster public engagement, and build a resilient translational science workforce. Through structured art-science–community interactions, this initiative demonstrates how artistic practice builds a new collaborative communication framework for linking early-career scientists, clinical translational research faculty, and the broader community. The conceptual novelty of our science-art initiative promises to break communication barriers, increase public trust, and develop new, accessible science narratives.
- Open Access
Quantifying Sleep-Wake Rhythms in the Hospital Environment with Digital Technologies
Postoperative clinical care is prone to circadian desynchronization that, in turn, may influence health outcomes. We collected 1.8 million data points using 11 remote sensors during preoperative, in-hospital and post-discharge settings in 13 elective cardiac surgery patients. We found that room traffic continued during nighttime with ≥1 visit/h. Sound levels exceeded the recommended 45 dBA threshold (51.9±3.3 versus 48.3±4.2 dBA during nighttime). Brightness dropped at night (89.9±87.7 to 3.7±9.8 lux), but bright light exposures occurred. Ambient room temperature lacked sleep-inducing diurnal variability. Behavioral-physiological rhythms were disrupted (decreased amplitude of heart rate variability; unadjusted-p - value =0.03) and phase-shifted during hospitalization. Time awake during night hours increased from 10.7±7.9% preoperatively to 34.8±29.1% in-hospital ( unadjusted p-value= 0.0098). Cognitive function scores decreased (26.8±2.8 points preoperatively to 24.7±3.9 points in-hospital) with 31% of patients developing transient mild impairment. These data will inform the design of a controlled trial seeking to modify circadian/diurnal disruptors to enhance patient outcomes.
Open AccessQuantifying Sleep-Wake Rhythms in the Hospital Environment with Digital Technologies
Postoperative clinical care is prone to circadian desynchronization that, in turn, may influence health outcomes. We collected 1.8 million data points using 11 remote sensors during preoperative, in-hospital and post-discharge settings in 13 elective cardiac surgery patients. We found that room traffic continued during nighttime with ≥1 visit/h. Sound levels exceeded the recommended 45 dBA threshold (51.9±3.3 versus 48.3±4.2 dBA during nighttime). Brightness dropped at night (89.9±87.7 to 3.7±9.8 lux), but bright light exposures occurred. Ambient room temperature lacked sleep-inducing diurnal variability. Behavioral-physiological rhythms were disrupted (decreased amplitude of heart rate variability; unadjusted-p - value =0.03) and phase-shifted during hospitalization. Time awake during night hours increased from 10.7±7.9% preoperatively to 34.8±29.1% in-hospital ( unadjusted p-value= 0.0098). Cognitive function scores decreased (26.8±2.8 points preoperatively to 24.7±3.9 points in-hospital) with 31% of patients developing transient mild impairment. These data will inform the design of a controlled trial seeking to modify circadian/diurnal disruptors to enhance patient outcomes.
- Open Access
- 18 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 40433
Critically ill patients with a reverse blood pressure dipping phenotype at increased risk for delirium and death
The ICU environment is disruptive to a patient’s biological rhythms where sleep-wake cycles are often desynchronized from the environmental day-night changes. This puts patients at increased risk to develop delirium with consequent fiscal pressure for the health care system. An underappreciated dimension is how time-specific patient phenotypes in the critical care environment relate to clinical outcomes. We set out to analyze how rhythmic components (or the lack thereof) in physiological data streams sampled at high resolution in the ICU were associated with the future incidence of delirium and death. To offer cues for further interrogation into mechanism and risk prognosis, we examined differences in 24-hour fluctuations of clinical labs in ICU patient populations at risk. Rhythmic components using dipping ratios and JTK_CYCLE statistics were derived from 24-hour blood pressure and heart rate measurements available from ICU patient admissions recorded in the MIMIC IV database. Logistic adjusted regression models assessed the association between disrupted vital sign rhythms and the future incidence of delirium during the same hospital admission and death. Aggregation of numeric clinical lab measurements across the first 24 h from all patient admissions allowed modeling of rhythmic patterns and subsequent association studies to link potential biochemical mechanisms to perturbed vital sign rhythms and adverse ICU outcomes. Patients with reverse blood pressure dipping were at a 40% higher risk to have a diagnosis of delirium (Odds Ratio: 1.38, 95% CI 1.13–1.71) and a 13% increased risk of death (Odds Ratio: 1.13, 95% CI 1.02–1.26). Compared to the patient population with nocturnal blood pressure dip, reverse dippers showed 24-hour biochemistry profiles suggestive of altered circadian programs specifically in clinical parameters of renal, metabolic, and hemostatic function. Reverse blood pressure dipping can be an early sign for the future development of delirium in the ICU and is accompanied by disrupted biorhythms across multiple organ systems. Dampened and reversed heart rate and blood pressure rhythms are associated with a higher risk for death in ICU patients. Considering the inclusion of these risk factors in preventive care may improve patient outcomes and reduce burden on the health care system.
- 18 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 40433
Open AccessCritically ill patients with a reverse blood pressure dipping phenotype at increased risk for delirium and death
The ICU environment is disruptive to a patient’s biological rhythms where sleep-wake cycles are often desynchronized from the environmental day-night changes. This puts patients at increased risk to develop delirium with consequent fiscal pressure for the health care system. An underappreciated dimension is how time-specific patient phenotypes in the critical care environment relate to clinical outcomes. We set out to analyze how rhythmic components (or the lack thereof) in physiological data streams sampled at high resolution in the ICU were associated with the future incidence of delirium and death. To offer cues for further interrogation into mechanism and risk prognosis, we examined differences in 24-hour fluctuations of clinical labs in ICU patient populations at risk. Rhythmic components using dipping ratios and JTK_CYCLE statistics were derived from 24-hour blood pressure and heart rate measurements available from ICU patient admissions recorded in the MIMIC IV database. Logistic adjusted regression models assessed the association between disrupted vital sign rhythms and the future incidence of delirium during the same hospital admission and death. Aggregation of numeric clinical lab measurements across the first 24 h from all patient admissions allowed modeling of rhythmic patterns and subsequent association studies to link potential biochemical mechanisms to perturbed vital sign rhythms and adverse ICU outcomes. Patients with reverse blood pressure dipping were at a 40% higher risk to have a diagnosis of delirium (Odds Ratio: 1.38, 95% CI 1.13–1.71) and a 13% increased risk of death (Odds Ratio: 1.13, 95% CI 1.02–1.26). Compared to the patient population with nocturnal blood pressure dip, reverse dippers showed 24-hour biochemistry profiles suggestive of altered circadian programs specifically in clinical parameters of renal, metabolic, and hemostatic function. Reverse blood pressure dipping can be an early sign for the future development of delirium in the ICU and is accompanied by disrupted biorhythms across multiple organ systems. Dampened and reversed heart rate and blood pressure rhythms are associated with a higher risk for death in ICU patients. Considering the inclusion of these risk factors in preventive care may improve patient outcomes and reduce burden on the health care system.